Cryptocurrency & Digital Assets

With a melanoma drug on track for 2027 and a deep pipeline, Immatics' 2025 net loss is part of a larger strategy to dominate PRAME cancer therapy.

With a new outpatient model, NexCure aims to bring life-saving cancer treatments like CAR-T closer to home, tackling a major healthcare bottleneck.

Biotech firm Immunis, Inc. secures a promising drug candidate to treat a debilitating side effect of Parkinson's therapy, offering hope to millions.

Canada's top cannabis firm launches a fast-acting drink, leveraging brand power and nano-tech to shake up the evolving beverage market.

Following key acquisitions, the AI firm pivots to a vertically integrated defense powerhouse, forecasting explosive growth backed by a swelling order backlog.

A Chinese firm's innovative probiotic packaging just won a top design award, solving a key industry problem and signaling a new era for 'Made in China'.

The Japanese giant is turning period poverty and gender disparity into a business model, using pads and education to unlock new markets in China, Brazil, and Kenya.

Record sales of its Trio® fertilizer fuel a major financial turnaround, as the company makes significant strides in extracting battery-grade lithium.

Ellington Credit reports a Q4 net loss amid a tough CLO market, yet management sees a major buying opportunity as asset prices get a reality check.

Backed by Nobel-winning science and French state support, Pasqal's move to go public validates the commercial promise of deep quantum technology.

A family-owned firm's push for eco-friendly practices and triple ISO certification is reshaping Sydney's competitive commercial cleaning industry.

With AI and disruption reshaping business, a new summit urges tech execs to lead like CEOs. Discover the 'Iconic Leadership' model for the enterprise of 2030.

Fintech firm LitXchange files a patent for blockchain-verified trade receipts, promising to give retail investors cryptographic proof of their transactions.

With alarming mortality rates, a major foundation is investing $3.5M in doula care and mental health, tackling a deep-rooted crisis from the ground up.

A new limited-edition MUDMASTER emerges from the desert, combining G-SHOCK's toughness with Toyota Team Land Cruiser's legendary Dakar Rally dominance.

Picsart launches Persona and Storyline, AI tools solving character consistency to empower the booming 'faceless' influencer and content creation market.

Tyson Foods' landmark deal with Arkansas isn't just about jersey patches; it's a new blueprint for NIL and corporate partnership in the NCAA.

Backed by JLL Partners, new platform Talica aims to unify the fragmented but vital surface science market for aerospace, pharma, and other high-tech industries.

Biotech firm ImmunoScape partners with a top US cancer center for a novel trial, backed by a strategic investment from actor Leonardo DiCaprio.

NFP enters the group captive space with a new practice led by veteran Alan Wise, aiming to give SMBs greater control over their insurance costs and risks.